NCT01690923

Brief Summary

The aim of this evaluation is to test:

  1. 1.Whether using nasal pillows at high pressures has comparable outcomes to nasal masks
  2. 2.Patient mask type preferences at high pressures

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 16, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 24, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

October 8, 2014

Completed
Last Updated

October 8, 2014

Status Verified

September 1, 2014

Enrollment Period

1.3 years

First QC Date

September 16, 2012

Results QC Date

September 26, 2014

Last Update Submit

October 7, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • AHI on Nasal Mask and Pillows Mask

    AHI (measure of sleep-disordered breathing severity) on nasal mask and nasal pillows measured as average events/hour

    7 days

Secondary Outcomes (1)

  • Usability

    After 7 days of use

Study Arms (2)

Nasal Mask First, then Pillows Mask

EXPERIMENTAL

Nasal mask is used for 7 nights, then followed by Pillows mask for 7 nights. \[Nasal mask=Mirage Activa, Micro, FX; Pillows mask=Swift FX\]

Device: Nasal maskDevice: Pillows mask

Pillows Mask, then Nasal Mask

EXPERIMENTAL

Pillows mask for 7 nights, then followed by Nasal mask is used for 7 nights. \[Nasal mask=MMirage Activa, Micro, FX; Pillows mask=Swift FX\]

Device: Nasal maskDevice: Pillows mask

Interventions

Nasal mask (Mirage Activa, Micro, FX)

Nasal Mask First, then Pillows MaskPillows Mask, then Nasal Mask

Nasal pillows mask (Swift FX)

Nasal Mask First, then Pillows MaskPillows Mask, then Nasal Mask

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients willing to give written informed consent
  • Patients who can read and comprehend English
  • Patients being treated for OSA for \>6 months
  • Patients ≥ 18 years of age
  • Patients using nasal mask systems with fixed pressure ≥ 12 cm H2O
  • Patients who can trial the trial masks up to 14 nights
  • Patients naive to pillows mask systems

You may not qualify if:

  • Patients using an inappropriate mask system
  • Patients using Bilevel flow generators
  • Patients who are pregnant
  • Patients who have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ResMed

Sydney, New South Wales, 2153, Australia

Location

Related Publications (1)

  • Zhu X, Wimms AJ, Benjafield AV. Assessment of the performance of nasal pillows at high CPAP pressures. J Clin Sleep Med. 2013 Sep 15;9(9):873-7. doi: 10.5664/jcsm.2984.

Limitations and Caveats

This study only included established CPAP users.

Results Point of Contact

Title
Xueling Zhu, Clinical Consultant
Organization
ResMed Ltd

Study Officials

  • Klaus Schindhelm, Prof

    ResMed

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2012

First Posted

September 24, 2012

Study Start

August 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

October 8, 2014

Results First Posted

October 8, 2014

Record last verified: 2014-09

Locations